Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is a rare vasculopathy, with high morbidity and mortality. The sensitivity of the current european society of cardiology/european respiratory society (ESC/ERS) risk assessment strategy may be improved by the addition of biomarkers related to PAH pathophysiology....

Descripción completa

Detalles Bibliográficos
Autores principales: Arvidsson, Mattias, Ahmed, Abdulla, Säleby, Joanna, Ahmed, Salaheldin, Hesselstrand, Roger, Rådegran, Göran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368940/
https://www.ncbi.nlm.nih.gov/pubmed/37502145
http://dx.doi.org/10.1002/pul2.12269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368940/
https://www.ncbi.nlm.nih.gov/pubmed/37502145
http://dx.doi.org/10.1002/pul2.12269

Ejemplares similares